• 5-year partnership with DKSH Malaysia for distribution of dental products
• Aims to establish Osteopore's products as the new gold standard in Guided Bone Regeneration
• Targets 20-30% Compound Annual Growth Rate over the first five years

Osteopore Limited, a global leader in 3D-printed biomimetic and bioresorbable implants, has announced a five-year partnership with DKSH Malaysia Sdn Bhd, a subsidiary of DKSH Holding Ltd, for the distribution of its dental products, Osteomesh® and Osteoplug®, in Malaysia. The dental products covered in this partnership are off-the-shelf products designed to assist in a surgical procedure known as Guided Bone Regeneration (GBR) where a combination of membrane, bone grafts, and/or bone substitutes are used to encourage new bone growth in areas where there is insufficient bone volume. Based on a market research report, the Malaysian GBR and Guided Tissue Regeneration market is projected to reach around USD$60 million by 2028 with a CAGR of 6.3%. Osteopore and DKSH Malaysia will focus on oral maxillofacial surgeons, prosthodontists, and periodontists, who are practicing predominantly in the major cities of Selangor and Kuala Lumpur, Johor, and Penang. Osteopore and DKSH Malaysia aim to triple the number of products currently supplied in the first year of partnership and become the new gold standard in Guided Bone Regeneration. This commercial collaboration builds on the prospective post-market clinical study in collaboration with Universiti Malaya (UM) that has recently commenced, where Osteopore's polycaprolactone membrane is being compared against collagen membrane.

Osteopore and DKSH Malaysia aim to target between 20-30% Compound Annual Growth Rate (CAGR) over the first five years of the partnership.

Osteopore and DKSH Malaysia are committed to driving strong and sustainable growth for the brand, supported by increasing clinical adoption and expanding market reach nationwide.